Table 6. Comparison of the characteristics between bacterial non-carriers and carriers in aneurysmal wall.
| Variable | Bacterial non-carrier in the aneurysmal wall (n = 19) | Bacterial carrier in the aneurysmal wall (n = 11) | P value |
|---|---|---|---|
| Age (y) | 68.9±6.2 | 66.0±7.2 | 0.26 |
| Male sex | 17 (90) | 11 (100) | 0.52 |
| BMIa (kg/m2) | 24.3±3.9 | 24.6±5.1 | 0.87 |
| Smoking | 18 (95) | 11 (100) | 1 |
| Hypertension | 11 (58) | 8 (73) | 0.47 |
| Diabetes | 6 (32) | 1 (9) | 0.22 |
| Aneurysm diameter (mm) | 51.9±11.8 | 52.5±7.5 | 0.87 |
| Thrombus thickness (mm) | 9.9±8.2 | 15.5±7.4 | 0.07 |
| Intraluminal thrombus volume (%) | 34.7±2.5 | 64.0±9.6 | 0.04 |
| Medication | |||
| PPIb/H2 blockerc | 5 (26) | 4 (36) | 0.69 |
| Statin | 9 (47) | 9 (82) | 0.12 |
| Intestinal drug | 1 (5) | 2 (18) | 0.54 |
| Differential count of leukocytes | |||
| Neutrophils (%) | 60.9±9.1 | 61.0±8.9 | 0.96 |
| Lymphocytes (%) | 26.5±7.1 | 28.3±7.8 | 0.54 |
| Monocytes (%) | 6.0±1.4 | 6.1±1.5 | 0.82 |
| NLR d | 2.67±1.74 | 2.42±1.10 | 0.67 |
| LMR e | 4.65±1.71 | 4.77±1.34 | 0.83 |
Data are presented as the mean ± standard error or number (%).
aBMI; body mass index.
bPPI; proton pomp inhibitor.
cH2 blocker; histamine H2-receptor antagonist.
dNLR; neutrophil-to-lymphocyte ratio.
eLMR; lymphocyte-to-monocyte ratio.